BR9805538A - Ferro-succinilcaseìna, processo para a preparação de ferro-succinilcaseìna, complexo férrico succinilado de caseìna alimentar, composição farmacêutica para o tratamento terapêutico de estados patológicos derivados de carência de ferro e uso do complexo férrico de caseìna alimentar succinilada. - Google Patents

Ferro-succinilcaseìna, processo para a preparação de ferro-succinilcaseìna, complexo férrico succinilado de caseìna alimentar, composição farmacêutica para o tratamento terapêutico de estados patológicos derivados de carência de ferro e uso do complexo férrico de caseìna alimentar succinilada.

Info

Publication number
BR9805538A
BR9805538A BR9805538-0A BR9805538A BR9805538A BR 9805538 A BR9805538 A BR 9805538A BR 9805538 A BR9805538 A BR 9805538A BR 9805538 A BR9805538 A BR 9805538A
Authority
BR
Brazil
Prior art keywords
ferro
succinylated
succinylcaseine
food
ferric complex
Prior art date
Application number
BR9805538-0A
Other languages
English (en)
Other versions
BR9805538B1 (pt
Inventor
Fausto Bonifacio
Pietro Massardo
Diego Di Leo
Original Assignee
Chemi Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemi Spa filed Critical Chemi Spa
Publication of BR9805538A publication Critical patent/BR9805538A/pt
Publication of BR9805538B1 publication Critical patent/BR9805538B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202Casein or caseinates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"FERRO-SUCCINILCASEìNA, PROCESSO PARA A PREPARAçãO DE FERRO-SUCCINILCASEìNA, COMPLEXO FéRRICO SUCCINILADO DE CASEìNA ALIMENTAR, COMPOSIçãO FARMACêUTICA PARA O TRATAMENTO TERAPêUTICO DE ESTADOS PATOLóGICOS DERIVADOS DA CARêNCIA DE FERRO E USO DO COMPLEXO FéRRICO DE CASEìNA ALIMENTAR SUCCINILADA". O objeto da presente invenção é um novo complexo férrico da caseína succinilada (indicada no texto como "ferro-succinilcaseína") obtido da caseína alimentar. Descreve-se além disso um processo para a preparação de ferro-succinilcaseína, em altos rendimentos e sem formação de resíduos insolúveis, a partir da caseína alimentar. A presente invenção se refere ainda às composições farmacêuticas compreendendo uma quantidade terapeuticamente eficaz de ferro-succinilcaseína em associação com excipientes, diluentes e conservantes apropriados de uso farmacêutico. O complexo férrico de acordo com a presente inveção é vantajosamente utilizado no tratamento terapêutico dos estados patológicos correlatos á carência de ferro; dito complexo é na verdade caracterizado pela ausência de efeitos colaterais e por elevada tolerabilidade.
BRPI9805538-0A 1997-12-24 1998-12-23 processo para a preparação de ferro-succinilcaseìna. BR9805538B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI002875A IT1297022B1 (it) 1997-12-24 1997-12-24 Complesso di ferro-succinilcaseina, processo per la sua preparazione e composizioni farmaceutiche che lo contengono

Publications (2)

Publication Number Publication Date
BR9805538A true BR9805538A (pt) 2000-02-01
BR9805538B1 BR9805538B1 (pt) 2009-05-05

Family

ID=11378454

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9805538-0A BR9805538B1 (pt) 1997-12-24 1998-12-23 processo para a preparação de ferro-succinilcaseìna.

Country Status (7)

Country Link
EP (1) EP0939083B1 (pt)
KR (1) KR100563361B1 (pt)
AR (1) AR020052A1 (pt)
BR (1) BR9805538B1 (pt)
ES (1) ES2212207T3 (pt)
IT (1) IT1297022B1 (pt)
PT (1) PT939083E (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE444303T1 (de) * 2005-12-06 2009-10-15 Vifor Int Ag Verfahren zur herstellung von ferrisuccinylcasein
WO2011117225A1 (de) 2010-03-23 2011-09-29 Vifor (International) Ag Fe(iii)-komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
PT2588488T (pt) * 2010-06-30 2017-06-26 Italfarmaco Spa Caseína-succinilato de ferro (iii) e método para a sua preparação
MY168952A (en) 2011-03-29 2019-01-28 Vifor Int Ag Fe (iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
AR086606A1 (es) 2011-05-31 2014-01-08 Vifor Int Ag Compuestos del complejo de fe(iii) para el tratamiento y profilaxis de los sintomas de la deficiencia de hierro y las anemias por deficiencia de hierro
CN102838667B (zh) * 2012-09-25 2014-06-25 济川药业集团有限公司 一种蛋白琥珀酸铁的制备方法
CN102836419B (zh) * 2012-09-25 2014-06-25 济川药业集团有限公司 一种蛋白琥珀酸铁口服溶液及其制备方法
CN105246473B (zh) 2012-12-21 2018-07-13 维福(国际)股份有限公司 用于缺铁症状和缺铁性贫血的治疗和预防的Fe(III)络合化合物
CN104402984B (zh) * 2014-11-11 2018-09-07 武汉科福新药有限责任公司 一种高载铁量的蛋白琥珀酸铁的制备方法
DK3034512T3 (en) 2014-12-19 2018-01-15 Ioulia Tseti A process for the preparation of iron (III)-casein-N-acetyl-aspartylated complexes and their use in pharmaceutical compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1222912B (it) * 1987-10-14 1990-09-12 Italfarmaco Spa Derivati polipeptidici a elevato tenore di ferro e altamente solubili atti alla terapia marziale procedimenti di preparazione e loro forme farmaceutiche
FR2651966B1 (fr) * 1989-09-20 1992-06-26 Sofalia Produit vegetal riche en fibres alimentaires, son procede de preparation et son utilisation en formulations alimentaires.

Also Published As

Publication number Publication date
KR19990063135A (ko) 1999-07-26
EP0939083A3 (en) 2001-10-04
BR9805538B1 (pt) 2009-05-05
EP0939083A2 (en) 1999-09-01
PT939083E (pt) 2004-04-30
EP0939083B1 (en) 2003-12-10
KR100563361B1 (ko) 2006-07-19
IT1297022B1 (it) 1999-08-03
AR020052A1 (es) 2002-04-10
ITMI972875A1 (it) 1999-06-24
ES2212207T3 (es) 2004-07-16

Similar Documents

Publication Publication Date Title
YU92501A (sh) Levodop/karbidop/entakapon farmaceutski preparat
BG103335A (en) Application of fumaric acid derivatives
BRPI9909282A (pt) compostos de éter aminociclohexílicos e usos dos mesmos.
BR9814484A (pt) "pró-drogas de inibidores de aspartil protease"
DE3568272D1 (en) 4-vinylbenzoic-acid derivatives, their preparation and their use as therapeutical compositions and as ligands
EP1961425A3 (en) Methods and compositions for the prevention and treatment of anemia
BR9805538A (pt) Ferro-succinilcaseìna, processo para a preparação de ferro-succinilcaseìna, complexo férrico succinilado de caseìna alimentar, composição farmacêutica para o tratamento terapêutico de estados patológicos derivados de carência de ferro e uso do complexo férrico de caseìna alimentar succinilada.
BR9809481A (pt) Composto, processo para sua preparação, uso do mesmo, composição farmacêutica, e, processos para sua preparação, para efetuar a imunossupressão e para tratar ou reduzir o risco de uma doença obstrutiva reversìvel das vias aéreas em um paciente
BRPI0316438C1 (pt) uso de eritropoietina em doenças cardíacas
BR9811086A (pt) Utilização de preparados de eritropoietina e ferro, processo para a produção de um preparado de combinação farmacêutica e embalagem unitária farmacêutica
KR880003620A (ko) 치료용 합성물 및 치료법(Therapeutic Composition and Method)
BR9609041A (pt) "terapia de substituição para cáries dentais".
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
CA2140361A1 (en) Composition and methods for decreasing muscle breakdown
BR0111506A (pt) Complexos de droga macromoleculares e composições contendo os mesmos
BR9912899A (pt) Peptìdeos derivados do tnf para uso no tratamento de edema
SE9801647D0 (sv) Therapeutic composition
BR0014979A (pt) Composição hormonal e sua utilização
HUP0102926A2 (hu) Karnitint és inozit-foszfátot tartalmazó, táplálékkiegészítőként vagy gyógyszerként alkalmazható készítmény
IL159241A0 (en) Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
BRPI0410844A (pt) fator de crescimento de fibroblasto de codificação de plasmìdeo para o tratamento de defeitos angiogênicos associados com hipercolesterolemia ou diabetes
PT1007040E (pt) Utilizacao de fanquinona no tratamento da doenca de alzheimer
MX9703810A (es) Medicamento que comprende un derivado de carnitinapara tratar la enfermedad de alzheimer en pacientes con inicio prematuro.
TR199700963T1 (xx) Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi.
AU3739500A (en) Protease resistant flint analogs

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved
B25A Requested transfer of rights approved

Free format text: ITALFARMACO S.P.A (IT)

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/06/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21A Expiry acc. art. 78, item i of ipl- expiry of the term of protection

Free format text: PATENTE EXTINTA EM 30.06.2019